EYT-30176-50903
1 vaccination
2 coded responses
3 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 214 / MD
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- Other
- Ethnicity
- N/A
Timeline
-
2021-03-25
Dose 1 — Moderna
-
2021-03-30
Registered in v-safe
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Anaphylactic reaction — Feeling: Poor · Site: Pain, Swelling, Itching · Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: AnaphylaxisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Swelling, Itching · Nausea, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-03-15
-
2022-03-27
Survey response — 12 months, dose 1MedDRA: Arthralgia, Chest pain, Headache, Myalgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Headaches, muscle/joint pains, chest painMedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Anaphylaxis
Release 11 — 12 months, dose 1
Symptoms: Headaches, muscle/joint pains, chest pain
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SRO | Anaphylactic reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release